Fused Pyrimidine-Based Drug Discovery

Fused Pyrimidine-Based Drug Discovery

1st Edition - September 1, 2022

Write a review

  • Author: Raj Kumar

Purchase options

No purchase options available.

Institutional Subscription

Free Global Shipping
No minimum order


Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico studies. It covers chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. N-Heterocyclic scaffolds are found in most known drug candidates and are of interest to medicinal and organic chemists to design, synthesize and evaluate their biological properties. A variety of fused-pyrimidine molecules have been synthesized and extracted from natural resources and are found to exhibit various biological activities such as antifolates, anticancer agents, analgesics, antimetabolites, CNS active agents, and many more.This book focuses on nomenclature, structural chemistry, and chemical and physical properties, along with various approaches for their synthesis. It is ideal for researchers in organic chemistry, both in academic and industrial settings and for postgraduates in chemistry and medicinal chemistry.

Key Features

  • Features synthetic schemes, approaches and strategies for fused pyrimidine scaffolds
  • Includes new fused-pyrimidine scaffolds, allowing the researcher to predict the mechanisms involved in their synthesis
  • Covers in silico studies of known fused pyrimidines and Structure Activity Relationship (SAR) that encourage the development of new or modified existing scaffolds with specific biological activities


Researchers in organic chemistry both in academic and industrial settings, postgraduates in chemistry and medicinal chemistry, researchers in pharmaceutical industries, chemical and pesticide industries

Table of Contents

  • 1. Introduction
    2. FDA Approved Fused Pyrimidine-Based Drugs
    3. Five-Membered Ring Fused Pyrimidine-Based Derivatives (eg. purines) and Biological Properties
    4. Six- Membered Ring Fused Pyrimidine-Based Derivatives (eg. Quinazolines, pteridines) and Biological Properties
    5. Seven-Membered Ring Fused Pyrimidine-Based Derivatives and Biological Properties
    6. Eight-Membered Fused Pyrimidine Derivatives (eg. azocine) and Biological Properties
    7. Naturally occurring fused pyrimidine derivatives and Medicinal Attributes
    8. Molecular Modeling Studies of Fused Pyrimidine Derivatives at various receptors

Product details

  • No. of pages: 320
  • Language: English
  • Copyright: © Elsevier 2022
  • Published: September 1, 2022
  • Imprint: Elsevier

About the Author

Raj Kumar

Dr. Raj Kumar, FRSC, is currently working as Dean of School of Health Sciences, and a Professor at the Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India. He obtained his Ph.D. in Medicinal Chemistry (2007) from NIPER, Mohali, India and completed his postdoctoral fellowship (2007-2008) at the University of Maryland Baltimore County (UMBC), Maryland where he co-invented a fused heterocycle RK-33 (Raj Kumar-33) molecule for the treatment of Lung Cancer. Dr. Kumar has published more than 90 peer-reviewed research papers (h index = 33; Scopus) in leading Medicinal/Organic/Pharmaceutical Chemistry Journals with a cumulative impact factor > 300. Dr. Kumar has been featured in the list of top 2% international scientists “Updated Science-wide Database of Stanford Citation Indicators” released by Stanford University, USA and published by Elsevier BV on 19th October 2021. His research interests focus on the design and synthesis of novel fused heterocycles of biological importance.

Affiliations and Expertise

Professor of Organic Medicinal Chemistry, Central University of Punjab, Bathinda, India

Ratings and Reviews

Write a review

There are currently no reviews for "Fused Pyrimidine-Based Drug Discovery"